General
A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
 

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Shared by:

 
Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.
 
www.nytimes.com
 
13 Aug 2017 - General